Cathie Wood acquired 34.8 Million Recursion Pharmaceuticals shares worth $153 Million. That's 1.55% of their equity portfolio (17th largest holding). The investor owns 6.79% of the outstanding Recursion Pharmaceuticals stock. The first Recursion Pharmaceuticals trade was made in Q2 2021. Since then Cathie Wood bought shares eleven more times and sold shares on four occasions. The investor's estimated purchase price is $336 Million, resulting in a loss of 54%.
Recursion Pharmaceuticals (NASDAQ: RXRX ) is one of the high-flying stocks gaining focus in today’s market. Indeed, shares of RXRX stock are rocketing more t...
Cathie Wood just gave the company a huge vote of confidence.